Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Am J Rhinol Allergy. 2012 Mar-Apr;26(2):110-6. doi: 10.2500/ajra.2012.26.3741.
Little is known regarding the epidemiology of chronic rhinosinusitis (CRS) in racial and ethnic minorities in the United States. This study was designed to comprehensively evaluate the current prevalence of CRS across various treatment settings to identify possible disparities in health care access and use between racial and ethnic populations.
The National Health Interview Survey (NHIS), National Ambulatory Medical Care Survey (NAMCS), and National Hospital Ambulatory Medical Care Survey (NHAMCS) database registries were extracted to identify the national prevalence of CRS in race/ethnic populations and resource use in ambulatory care settings. Systematic literature review identified studies reporting treatment outcomes in minority patients electing endoscopic sinus surgery (ESS). Data were supplemented using a multi-institutional cohort of patients undergoing surgical treatment.
National survey data suggest CRS is a significant health condition for all major race/ethnic groups in the United States, accounting for a sizable portion of office, emergency, and outpatient visits. Differences in insurance status, work absenteeism, and resource use were found between race/ethnic groups. Despite its prevalence, few published studies include information regarding minority patients with CRS. Most (90%) cohort studies did not provide details of race/ethnicity for ESS outcomes. Prospective cohort analysis indicated that minority surgical patients accounted for only 18%, when compared with national census estimates (35%).
CRS is an important health condition for all major race/ethnic groups in the United States. Significant differences may exist across racial and ethnic categories with regard to CRS health status and health care use. Given current demographic shifts in the United States, specific attention should be given to understanding CRS within the context of racial and ethnic populations. Public clinical trial registration (www.clinicaltrials.gov) I.D. No. NCT00799097.
在美国，种族和少数民族人群慢性鼻-鼻窦炎（CRS）的流行病学情况鲜为人知。本研究旨在全面评估各种治疗环境中 CRS 的当前流行率，以确定不同种族和族裔人群在医疗保健获取和使用方面可能存在的差异。
从国家健康访谈调查（NHIS）、国家门诊医疗保健调查（NAMCS）和国家医院门诊医疗保健调查（NHAMCS）数据库中提取数据，以确定种族/族裔人群中 CRS 的全国流行率以及在门诊护理环境中的资源利用情况。系统文献综述确定了报告少数民族患者内镜鼻窦手术（ESS）治疗结果的研究。使用接受手术治疗的多机构患者队列来补充数据。
国家调查数据表明，CRS 是美国所有主要种族/族裔群体的重大健康问题，占门诊、急诊和门诊就诊的相当大一部分。不同种族/族裔群体之间存在保险状况、旷工和资源利用方面的差异。尽管 CRS 很普遍，但很少有研究报告少数民族患者的相关信息。大多数（90%）队列研究未提供 ESS 结果的种族/族裔详细信息。前瞻性队列分析表明，与国家人口普查估计数（35%）相比，少数民族手术患者仅占 18%。
CRS 是美国所有主要种族/族裔群体的重要健康问题。在 CRS 健康状况和医疗保健使用方面，不同种族和族裔类别之间可能存在显著差异。鉴于美国目前的人口结构变化，应特别关注在种族和族裔人群背景下了解 CRS。公共临床试验注册（www.clinicaltrials.gov）注册号 NCT00799097。
